APA (7th ed.) Citation

Budde, K., Becker, T., Arns, W., Sommerer, C., Reinke, P., Eisenberger, U., . . . Pietruck, F. (2011). Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: An open-label, randomised, controlled trial. The lancet, 377(9768), . https://doi.org/10.1016/S0140-6736(10)62318-5

Chicago Style (17th ed.) Citation

Budde, Klemens, et al. "Everolimus-based, Calcineurin-inhibitor-free Regimen in Recipients of De-novo Kidney Transplants: An Open-label, Randomised, Controlled Trial." The Lancet 377, no. 9768 (2011). https://doi.org/10.1016/S0140-6736(10)62318-5.

MLA (9th ed.) Citation

Budde, Klemens, et al. "Everolimus-based, Calcineurin-inhibitor-free Regimen in Recipients of De-novo Kidney Transplants: An Open-label, Randomised, Controlled Trial." The Lancet, vol. 377, no. 9768, 2011, https://doi.org/10.1016/S0140-6736(10)62318-5.